PARIS: French-Austrian drugmaker Valneva’s vaccine candidate against chikungunya, a mosquito-borne virus which causes occasional outbreaks across the world, showed promising results in a large new trial, a study said on Tuesday.While the results were hailed as good news in the fight against chikungunya, the trial was carried out on people in the United States where the virus is extremely rare, with experts saying more research was needed.There are currently no vaccines or treatments available for the virus, which causes fever and sometimes debilitating joint pain, though it is rarely fatal.Valneva says that its vaccine candidate, called VLA1553, is the first to be reviewed by health authorit
Hence then, the article about positive results for potential first chikungunya vaccine was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Positive results for potential first chikungunya vaccine )